InsidersTradesSigma
Discover the detailed record of transactions filed by Franchi Jean M., Chief Financial Officer. Insider active across 2 companies, notably BIODESIX INC. Cumulatively, 3 reports have been published. Total volume traded: €48k. The latest transaction was filed on 16 May 2022 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations
Jean M. Franchi is the Chief Financial Officer at Biodesix Inc and Replimune Group, Inc. In this role, he is responsible for the financial management of both companies, which focus on developing diagnostic and therapeutic solutions. Jean brings valuable financial expertise, contributing to the growth and sustainability of the companies.